This episode was originally released on December 21, 2022 | In this post-election special edition episode of Holland & Knight Public Policy & Regulation Group's "The Eyes on Washington" podcast series, healthcare attorneys Sara Klock and Michael Werner discuss how the elections will impact the U.S. Food and Drug Administration (FDA) and what can be expected in terms of agency regulation and related legislation. The conversation takes an in-depth look at FDA's stance on digital health products, cannabis and laboratory developed tests. Our hosts also express that the industry should be prepared for an uptick in enforcement and explain how Holland & Knight guides clients through the regulation process.